Evidence map›Paper›PMID 29233117›Full record

ArticleBMC infectious diseases2017

Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency: a case report.

Przemysław Zdziarski, Mariola Paściak, Klaudia Rogala, Agnieszka Korzeniowska-Kowal, Andrzej Gamian

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Transmission and genomic insights intoOne health (Amsterdam, Netherlands) · 2026
    Article
  2. Article
  3. BMJ case reports · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Outbreaks ofTransboundary and emerging diseases · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Genomic analysis ofCurrent research in microbial sciences · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Frontiers in medicine · 2021
    Article
  17. Article
  18. Access microbiology · 2020
    Article
  19. Microorganisms · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Przemysław ZdziarskiDepartment of Clinical Immunology, Lower Silesian Center for Cellular Transplantation, PO Box 1818, 50-385, Wrocław-46, Poland.
Mariola PaściakHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland. pasciak@iitd.pan.wroc.pl.
Klaudia RogalaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.
Agnieszka Korzeniowska-KowalHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.
Andrzej GamianHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLPolish Academy of Sciences · PLSilesian Center for Heart Disease · PL

Funding

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences 501-15/2016
6 · The paper itself

Abstract

backgroundElizabethkingia miricola is a rare Gram-negative bacterium found in water and clinical specimens. Typical culturing methods often misidentify Elizabethkingia spp. as Flavobacterium or Chryseobacterium. Although diagnosis is based on culturing samples taken from sterile sites, such as blood, a proper identification of this bacterium requires an expertise that goes beyond the capabilities of a typical clinical laboratory. CASE PRESENTATION: A 35-year-old woman diagnosed with common variable immunodeficiency was admitted to our center. Previous treatment with antibiotics (amoxicillin plus clavulanate, first and third generation of cephalosporins, macrolides) and systemic corticosteroids (up to 120 mg/day of prednisolone) failed to arrest the spread of inflammation. Gingival recession was observed in her oral cavity, resulting in an apparent lengthening of her teeth. In addition to typical commensal bacteria, including streptococci and neisseriae, strains of Rothia mucilaginosa and Elizabethkingia miricola were identified upon a detailed microbiological examination using a MALDI-TOF MS Biotyper system. The presence of the latter strain correlated with severe periodontitis, lack of IgA in her saliva and serum, a very low IgG concentration (< 50 mg/dl), IgM-paraproteinemia, decreases in C3a and C5a and microvascular abnormality. High-dose immunoglobulin (to maintain IgG > 500 mg/dl) and targeted levofloxacin treatment resulted in immune system reconstitution, oral healing, and eradication of the Elizabethkingia infection.

conclusionsE. miricola rarely causes disease in healthy individuals. However, the overgrowth of commensal bacteria, lack of IgG/IgA, microvasculopathy and complement cascade activation in patients with humoral immunodeficiency may facilitate Elizabethkingia invasion. Overuse of antibiotics, particularly beta-lactams, may cause mucosal colonization by E. miricola, followed by its multiplication combined with periodontitis that prompts bacterial translocation. MALDI-TOF Biotyper analysis may become a method of choice for identification of Elizabethkingia infections.

Indexed as

Adrenal Cortex HormonesAdultAnti-Bacterial AgentsComplement C3aComplement C5aFemaleFlavobacteriaceaeGram-Negative Bacterial InfectionsHumansImmunity, HumoralImmunoglobulin AImmunoglobulins, IntravenousLevofloxacinMouthPeriodontitisRNA, Ribosomal, 16SAdrenal Cortex HormonesAnti-Bacterial AgentsComplement C3aComplement C5aImmunoglobulin AImmunoglobulins, IntravenousLevofloxacinRNA, Ribosomal, 16SElizabethkingia miricolaMALDI-TOF BiotyperNatural history of diseasePeriodontitisPortal of entrySuperinfection

Identifiers

PMID29233117
PMCPMC5727958
OpenAlexW2772896333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.